A validated mathematical model of cell-mediated immune response to tumor growth

Cancer Research

Volumn 65, Issue 17, 2005, Pages 7950-7958

  De Pillis, Lisette G ^a   Radunskaya, Ami E ^b   Wiseman, Charles L ^c  

^a HARVEY MUDD COLLEGE   (United States)

^b POMONA COLLEGE   (United States)

^c ST VINCENT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; LIGAND;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; MELANOMA; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL GROWTH PROCESSES; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MICE; MODELS, IMMUNOLOGICAL; NEOPLASMS; VACCINATION;

EID: 24744472075     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0564     Document Type: Article

References (31)

1. Murray JM. Mathematical Biology. 2nd ed. Berlin: Springer-Verlag; 1993.
2. Eisen M. Mathematical models in cell biology and cancer chemotherapy. Berlin: Springer-Verlag; 1979.
3. Bellomo N, Preziosi L. Modelling and mathematical problems related to tumor evolution and its interaction with the immune system. Mathematical and Computer Modelling 2000;32:413-52.
4. Coldman AJ, Goldie JH. A stochastic model for the origin and treatment of tumors containing drug-resistant cells. Bull Math Biol 1986;48:279-92.
5. Simulation in cancer research (Durham, N.C., 1986).
6. Skipper HE. On mathematical modeling of critical variables in cancer treatment (Goals: better understanding of the past and better planning in the future). Bull Math Biol 1986;48:253-78.
7. Simulation in cancer research (Durham, N.C., 1986).
8. Diefenbach A, Jensen E, Jamieson A, Raulet D. Rael and H60 ligands of the NKG2D receptor stimulate tumor immunity. Nature 2001;413:165-71.
9. Dudley ME, Wunderlich JR, Robbins PF, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002;298:850-4.
10. de Pillis L, Radunskaya A. A mathematical tumor model with immune resistance and drug therapy: an optimal control approach. Journal of Theoretical Medicine 2001;3:79-100.
11. de Pillis L, Radunskaya A. The dynamics of an optimally controlled tumor model: a case study. Mathematical and Computer Modelling 2003;37:1221-44.
12. Kuznetsov V, Makalkin I, Taylor M, Perelson A. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. Bull Math Biol 1994;56:295-321.
13. Lin AH. A model of tumor and lymphocyte interactions. Discrete and Continuous Dynamical Systems-Series B 2004;4:241-66.
14. Arciero J, Jackson T, Kirschner D. A mathematical model of tumor-immune evasion and siRNA treatment. Discrete and Continuous Dynamical Systems-Series B 2004;4:39-58.
15. Burden T, Ernstberger J, Fister K. Optimal control applied to immunotherapy. Discrete and Continuous Dynamical Systems-Series B 2004;4:135-48.
16. Sotolongo-Costa O, Morales Molina L, Rodriguez Perez D, Antoranz J, Chacon Reyes M. Behavior of tumors under nonstationary therapy. Physica D 2003;178:242-53.
17. Delitala M. Critical analysis and perspectives on kinetic (Cellular) theory of immune competition. Mathematical and Computer Modelling 2002;35:63-75.
18. Kuznetsov V, Knott G. Modeling tumor regrowth and immunotherapy. Mathematical and Computer Modelling 2001;33:1275-87.
19. Firmani B, Guerri L, Preziosi L. Tumor/immune system competition with medically induced activation/deactivation. Mathematical Models and Methods in Applied Sciences 1999;4:491-512.
20. Owen M, Sherratt J. Mathematical modelling macrophage dynamics in tumors. Mathematical Models and Methods in Applied Sciences 1999;9:513-39.
21. Kirschner D, Panetta J. Modeling immunotherapy of the tumor-immune interaction. J Math Biol 1998;37:235-52.
22. Michelson S, Leith J. Host response in tumor growth and progression. Invasion Metastasis 1996;16:235-46.
23. Zaloj V, Rotaru AK, Barbaroshie A, Van Driessche W, Frangopol P. Nonlinear dynamics of the immune system interaction with the bilocal cancer tumor. Journal of Biological Physics 1995;21:155-76.
24. Nani F, Oguztoreli M. Modeling and simulation of Rosenberg-type adoptive cellular immunotherapy. IMA J Math Appl Med Biol 1994;11:107-47.
25. Adam JA. The dynamics of growth-factor-modified immune response to cancer growth: one-dimensional models. Mathematical and Computer Modelling 1993;17:83-106.
26. Kuznetsov V, Makalkin I. Bifurcation-analysis of mathematical-model of interactions between cytotoxic lymphocytes and tumor-cells - effect of immunological amplification of tumor-growth and its connection with other phenomena of oncoimmunology. Biofizika 1992;37:1063-70.
27. Hart D, Shochat E, Agur Z. The growth law of primary breast cancer as inferred from mammography screening trials data. Br J Cancer 1998;78:382-7.
28. Farkas M. Dynamical models in biology. San Diego, CA: Academic Press: 2001.
29. Yates A, Callard R. Cell death and the maintenance of immunological memory. Discrete and Continuous Dynamical Systems 2002;1:43-59.
30. Britton NF. Essential mathematical biology. Springer Verlag; 2003.
31. Lanzavecchia A, Sallusto F. Dynamics of T-lymphocyte responses: intermediates, effectors, and memory cells. Science 2000;290:92-7.